Explore 3 Stock Ideas & Industry Insights Download Free Report

LBT Innovations Ltd

Company price
None AUD 0.00(0%)
Last update at 2025-02-27T06:20:48.764361Z
Market Cap
29.89M

Momentum Score

…

Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. The company was formerly known as LBT Innovations Limited and changed its name to Clever Culture Systems Limited in November 2024. Clever Culture Systems Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
1.26M
Revenue Per Share
0.00
Gross Profit TTM
1.11M
Debt / Equity
1.32
ROE
-322.69%
Net Debt
0.85M
ROCE
-109.37%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -20.88M -8.76M -9.50M -7.42M -5.99M
Net income -22.52M -6.64M -7.26M -5.64M -4.35M
Selling general administrative 4.47M 5.19M 4.67M 4.12M 2.12M
Selling and marketing expenses 0.09M 0.28M - - 0.10M
Gross profit 1.71M 1.33M 1.12M 1.16M 2.33M
Reconciled depreciation 3.30M 2.93M 2.40M 2.43M 2.15M
Ebit -7.00M -8.65M -9.39M -7.30M -5.97M
Ebitda -3.71M -5.72M -6.99M -4.87M -3.82M
Depreciation and amortization 3.30M 2.93M 2.40M 2.43M 2.15M
Operating income -7.00M -8.65M -9.39M -7.30M -5.97M
Other operating expenses 9.17M 10.03M 7.78M 7.29M 6.46M
Interest expense 0.47M 0.10M 0.12M 0.11M 0.02M
Tax provision 1.64M -2.12M -2.24M -1.78M -1.64M
Interest income 0.47M 1.63M 3.83M 1.76M 2.30M
Net interest income -0.45M -0.10M -0.04M -0.11M 0.12M
Income tax expense 1.64M -2.12M -2.24M -1.78M -1.64M
Total revenue 2.13M 2.13M 1.12M 1.16M 2.55M
Total operating expenses 8.74M 9.23M 7.78M 7.29M 6.24M
Cost of revenue 0.43M 0.80M - 0.00M 0.22M
Total other income expense net -13.29M -0.10M -0.12M -0.11M -0.02M
Net income from continuing ops -22.52M -6.64M -7.26M -5.64M -4.35M
Net income applicable to common shares -22.52M -6.64M -7.26M -5.64M -4.35M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 7.93M 7.37M 31.52M 35.69M 33.77M
Intangible assets - 0.00M 16.15M 14.82M 16.56M
Other current assets - 0.85M 1.21M 0.87M 0.73M
Total liab 5.51M 7.47M 10.19M 10.81M 9.65M
Total stockholder equity 2.42M -0.10M 21.34M 24.88M 24.11M
Deferred long term liab - - 16.15M 14.82M 16.56M
Other current liab 0.88M 2.02M 0.85M 0.01M 0.03M
Common stock 53.11M 47.02M 46.27M 43.54M 35.55M
Capital stock - 47.02M 46.27M 43.54M 35.55M
Retained earnings -52.77M -49.07M -26.59M -19.96M -12.71M
Other liab - 1.09M 4.20M 4.50M 5.08M
Other assets - 0.86M 22.63M 22.04M 25.76M
Cash 2.35M 2.02M 2.79M 9.62M 7.10M
Cash and equivalents - 0.16M 2.79M 8.78M 6.62M
Total current liabilities 1.53M 4.19M 2.86M 2.58M 1.64M
Current deferred revenue - 0.29M 0.03M 0.04M -0.03M
Net debt 0.85M 1.37M 1.50M -4.76M -3.20M
Short term debt 0.21M 1.19M 1.16M 1.13M 0.96M
Short long term debt - 0.99M 0.96M 0.95M 0.95M
Short long term debt total 3.19M 3.39M 4.29M 4.86M 3.90M
Other stockholder equity - -1.83M -1.93M -2.21M -1.72M
Property plant equipment - 1.67M 1.92M 2.08M 0.07M
Total current assets 5.52M 4.84M 6.98M 11.57M 7.93M
Long term investments - - - 4.69M 7.29M
Net tangible assets - -0.10M 21.34M 24.88M 24.11M
Net receivables 1.56M 0.48M 2.00M 1.08M 0.11M
Long term debt - 0.76M 1.50M 1.99M 2.97M
Inventory 1.62M 1.49M 0.98M - -
Accounts payable 0.44M 0.68M 0.82M 1.41M 0.68M
Accumulated other comprehensive income 2.09M 1.95M 1.65M 1.30M 1.28M
Common stock total equity - - - - 35.55M
Non currrent assets other - - - - 0.37M
Non current assets total 2.41M 2.53M 24.55M 24.12M 25.83M
Capital lease obligations - 1.64M 1.82M 1.92M 0.01M
Long term debt total - 2.19M 3.13M 3.73M 2.97M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.30M -1.24M -1.74M -2.46M -3.75M
Change to liabilities 2.52M -1.61M -0.58M -0.98M -1.64M
Total cashflows from investing activities -0.30M -1.24M -1.74M -2.46M -3.75M
Net borrowings -0.90M -0.64M -0.98M 1.29M 2.50M
Total cash from financing activities 0.94M -0.64M 6.93M 1.24M 7.16M
Change to operating activities 0.00M 0.07M 0.14M 0.05M 0.25M
Net income -22.52M -6.64M -7.26M -5.64M -4.35M
Change in cash -0.77M -6.83M 2.52M -3.08M 2.60M
Begin period cash flow 2.79M 9.62M 7.10M 10.18M 7.57M
End period cash flow 2.02M 2.79M 9.62M 7.10M 10.18M
Total cash from operating activities -1.40M -3.71M -2.67M -1.85M -0.81M
Issuance of capital stock 2.00M - 8.47M 0.01M 4.99M
Depreciation 0.25M 2.93M 2.40M 2.43M 2.15M
Other cashflows from investing activities 0.00M -0.33M -1.11M -1.69M -1.48M
Dividends paid - - - 0.14M -
Change to inventory -0.51M 0.30M 0.30M 0.30M 0.30M
Change to account receivables 1.52M -1.43M -0.97M 0.19M -0.05M
Sale purchase of stock -0.17M 0.00M -0.56M -0.06M -0.33M
Other cashflows from financing activities -0.18M -0.16M -0.05M 1.50M 2.50M
Change to netincome 13.94M 1.76M 3.74M 1.80M 2.17M
Capital expenditures 0.30M 0.66M 0.67M 0.77M 2.27M
Change in working capital 1.45M 1.68M 2.24M 2.70M 4.35M
Other non cash items - 3.71M 4.86M 3.21M 2.20M
Free cash flow -0.30M -4.37M -0.67M -0.77M -2.27M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COH
Cochlear Ltd
2.26
1.50%
152.98 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc
0.06
4.72%
1.33 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp
0.50
5.88%
9.00 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc
-0.11
2.13%
5.06 - 9.97 9.59 7.17 6.76 15.37

Profile*

LBT Innovations Ltd

Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. The company was formerly known as LBT Innovations Limited and changed its name to Clever Culture Systems Limited in November 2024. Clever Culture Systems Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

16 Anster Street, Adelaide, SA, Australia, 5000

61 8 8227 1555

Name Title Year Born
Mr. Brenton John Barnes CEO, MD & Director NA
Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert) CFO & Company Sec. NA
Mr. Peter M. Bradley VP of Global Bus. Devel. NA
Mr. Pablo Cesar Solis Madrigal Director of Technology Devel. NA
Dr. Steven Giglio Scientific Director NA
Mr. Jack Brown Corp. Devel. Director NA
Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert) CFO, Company Secretary & Director NA
Mr. Jack Brown Corporate Development Director NA
Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert) CFO, Company Secretary & Director NA
Mr. Jack Brown Corporate Development Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…